Pharmacokinetics, Short Term Safety
and Efficacy of the Approved Once-Daily Darunavir/r
Dosing Regimen in HIV-Infected Children.
Bastiaans DET, Geelen SPM, Visser EG, et al
Pediatr Infect Dis J.
2018 Feb 22
Abstract
Characteristics and early outcomes of
children and adolescents treated with
darunavir/ritonavir-, raltegravir- or
etravirine-containing antiretroviral therapy in the
Western Cape Province of South Africa.
Nuttall J, Pillay V.
S Afr Med J. 2018
Feb 1;
Abstract
Pharmacokinetics of Once-Daily
Darunavir/Ritonavir With and Without Etravirine in
Human Immunodeficiency Virus-Infected Children,
Adolescents, and Young Adults.
Larson KB, Cressey TR, Yogev R, et al
Pediatric Infect Dis Soc.
2016 Jun;5(2):131-7
Abstract
Safety
of darunavir and atazanavir in HIV-infected children
in Europe and Thailand.
European
Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC)
study group in EuroCoord.
Antivir Ther.
2015 Nov 12.
Abstract
Darunavir: A Review in Pediatric
HIV-1 Infection.
Keating GM.
Paediatr Drugs.
2015 Sep 1.
Abstract
Model-Based Once-Daily
Darunavir/Ritonavir Dosing Recommendations in
Pediatric HIV-1-Infected Patients Aged 3 to 12 Years
Brochot A, Kakuda TN, Van De Casteele T,
CPT Pharmacometrics Syst Pharmacol.
2015 Jul;4(7):406-414.
Abstract
Desensitization to darunavir in a pediatric patient
Cambray-Gutiérrez
JC, López-Pérez P, Chávez-García AA,
Rev Alerg Mex.
2015 Jul-Sep;62(3):251-254
Abstract
Safety and Efficacy of Darunavir/Ritonavir in
Treatment-experienced Pediatric Patients: Week 48 Results of
the ARIEL Trial.
Violari A, Bologna R, Kumarasamy N, et al
Pediatr Infect Dis J.
2015 Feb 21.
Abstract
Pharmacokinetics and efficacy of
darunavir/ritonavir once daily in virologically suppressed,
treatment-experienced HIV-infected children.
Chokephaibulkit K, Rungmaitree S, Phongsamart W, et al
HIV Med.
2014 Sep;15(8):511-2.
Abstract
Early Outcomes of Darunavir- and/or
Raltegravir-based Antiretroviral Therapy in Children with
Multidrug-Resistant HIV at a Pediatric Center in Botswana.
Kirk BL, Gomila A, Matshaba M, et al
J Int Assoc Physicians AIDS Care (Chic).
2013 Jan 11
Abstract
Profile of darunavir in the treatment of
HIV-infected pediatric and adolescent patients.
Dobroszycki J, Abadi J, Wiznia AA, Rosenberg MG.
Adolesc Health Med Ther.
2011 Sep 14;2:85-93
Abstract
The prevalence of darunavir-associated mutations in
HIV-1-infected children in the UK.
Donegan KL, Walker AS, Dunn D,
Antivir Ther. 2011 Dec 15.
Abstract |
New
and Noteworthy
Protease
Inhibitors: General Data
ARV
Drugs Main Page
Main
New/Newsworthy
Documents
identified with this icon are in Portable Document Format (PDF) and require the
